3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Multiple Myeloma
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Neoplasms, Plasma Cell
14
Recurrence
12
Leukemia
12
Vomiting
11
Lymphoma, Extranodal NK-T-Cell
11
Lymphoma
11
Neoplasms
9
Nausea
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Paraproteinemias
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphohistiocytosis, Hemophagocytic
3
Lung Neoplasms
3
Immunoglobulin Light-chain Amyloidosis
3
Hematologic Diseases
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Blood Protein Disorders
3
Renal Insufficiency
2
Postoperative Nausea and Vomiting
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Interventions
pembrolizumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gemcitabine
2
Cisplatin
2
niraparib
1
dostarlimab
1
defactinib
1
Vitamin B 12
1
TroVax
1
Thiostrepton
1
Sorafenib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Mitomycin
1
MAC321
1
Leucovorin
1
Immunotherapy, Adoptive
1
Imatinib Mesylate
1
IPI-549
1
Folic Acid
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma
×
Dexamethasone
×
Clear all
NCT01569919
2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2
Unknown
26 enrolled